Nocardiosis in graft recipients of kidneys from extended-criteria donors following switch to belatacept complicated by acute rejection

Transpl Int. 2020 Nov;33(11):1565-1568. doi: 10.1111/tri.13722. Epub 2020 Sep 16.

Authors

Simon Ville^{1

2}, Benjamin Gaborit³, Jeremy Meyer⁴, Christophe Masset², Lescornet Tanguy², Claire Garandeau²

Affiliations

¹ Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
² Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.
³ Infectious Diseases Department, Centre Hospitalier Universitaire, Nantes, France.
⁴ Radiology Department, Centre Hospitalier Universitaire, Nantes, France.

PMID: 32866997
DOI: 10.1111/tri.13722

No abstract available

Publication types

Letter

MeSH terms

Abatacept
Graft Rejection
Graft Survival
Humans
Immunosuppressive Agents
Kidney
Nocardia Infections* / drug therapy
Tissue Donors
Transplant Recipients*

Substances

Immunosuppressive Agents
Abatacept